Document:

EX-4.2

 

Exhibit 4.2

AMERICAN EXPRESS CREDIT ACCOUNT MASTER TRUST

OMNIBUS AMENDMENT

TO SERIES SUPPLEMENTS

          OMNIBUS AMENDMENT, dated as of March 5, 2008 (this “Amendment”), to the Supplements
(as hereinafter described) to the Pooling and Servicing Agreement, dated as of May 16, 1996, as
amended and restated as of January 1, 2006 (as so amended and restated and in effect on the date
hereof, the “Agreement”), among American Express Receivables Financing Corporation II, a
Delaware corporation (“RFC II”), American Express Receivables Financing Corporation III
LLC, a Delaware limited liability company (“RFC III”), and American Express Receivables
Financing Corporation IV LLC, a Delaware limited liability company (“RFC IV”), as
Transferors, American Express Travel Related Services Company, Inc., a New York corporation
(“TRS”), as Servicer, and The Bank Of New York, a New York banking corporation, as Trustee
(the “Trustee”).

RECITALS

          WHEREAS, RFC II, RFC III and RFC IV (or their predecessors in interest, as applicable), as
Transferors, TRS, as Servicer, and the Trustee have previously entered into (i) the Series 2001-5
Supplement, dated as of May 9, 2001 (as amended, the “Series 2001-5 Supplement”), (ii) the
Series 2002-1 Supplement, dated as of February 21, 2002 (as amended, the “Series 2002-1
Supplement”), (iii) the Series 2002-2 Supplement, dated as of April 25, 2002 (as amended, the
“Series 2002-2 Supplement”), (iv) the Series 2002-3 Supplement, dated as of May 16, 2002
(as amended, the “Series 2002-3 Supplement”), (v) the Series 2002-5 Supplement, dated as of
July 17, 2002 (as amended, the “Series 2002-5 Supplement”), (vi) the Series 2002-6
Supplement, dated as of August 15, 2002 (as amended, the “Series 2002-6 Supplement”), (vii)
the Series 2003-1 Supplement, dated as of February 20, 2003 (as amended, the “Series 2003-1
Supplement”), (viii) the Series 2003-2 Supplement, dated as of April 2, 2003 (as amended, the
“Series 2003-2 Supplement”), (ix) the Series 2003-3 Supplement, dated as of May 7, 2003
(as amended, the “Series 2003-3 Supplement”), (x) the Series 2004-1 Supplement, dated as of
March 1, 2004 (as amended, the “2004-1 Supplement”), (xi) the Series 2004-2 Supplement,
dated as of June 2, 2004 (as amended, the “2004-2 Supplement”), (xii) the Series 2004-3
Supplement, dated as of June 2, 2004 (as amended, the “2004-3 Supplement”), (xiii) the
Series 2004-4 Supplement, dated as of August 17, 2004 (as amended, the “2004-4
Supplement”), (xiv) the Series 2004-5 Supplement, dated as of September 23, 2004 (as amended,
the “2004-5 Supplement”), (xv) the Series 2005-1 Supplement, dated as of March 24, 2005 (as
amended, the “2005-1 Supplement”), (xvi) the Series 2005-2 Supplement, dated as of March
24, 2005 (as amended, the “2005-2 Supplement”), (xvii) the Series 2005-3 Supplement, dated
as of June 17, 2005 (as amended, the “2005-3 Supplement”), (xviii) the Series 2005-4
Supplement, dated as of June 17, 2005 (as amended, the “2005-4 Supplement”), (xix) the
Series 2005-5 Supplement, dated as of July 21, 2005 (as amended, the “2005-5 Supplement”),
(xx) the Series 2005-6 Supplement, dated as of
August 18, 2005 (as amended, the “2005-6 Supplement”), (xxi) the Series 2005-7
Supplement,

 

 

dated as of August 18, 2005 (as amended, the “2005-7 Supplement”), and (xxii)
the Series 2005-8 Supplement, dated as of November 22, 2005 (as amended, the “2005-8
Supplement”);

          WHEREAS, each of the series supplements listed in the preceding paragraph are, collectively,
the “Supplements”;

          WHEREAS, the parties to each of the Supplements now wish to amend the Supplements as set forth
herein;

          WHEREAS, pursuant to Section 13.01(a) of the Agreement, each of RFC II, RFC III and RFC IV has
delivered to the Trustee an Officer’s Certificate, dated the date of this Amendment, stating that
RFC II, RFC III and RFC IV, respectively, reasonably believes that this Amendment will not have an
Adverse Effect; and

          WHEREAS, RFC II, RFC III, RFC IV and the Servicer have satisfied all conditions precedent
contained in the Pooling and Servicing Agreement to entering into this Amendment and this Amendment
is authorized and permitted under the Pooling and Servicing Agreement.

          NOW, THEREFORE, in consideration of the mutual agreements herein contained, and other good and
valuable consideration, the receipt and adequacy of which are hereby acknowledged, each party
hereto agrees as follows:

ARTICLE I

DEFINITIONS

          SECTION 1.01. Defined Terms Not Defined Herein. All capitalized terms used herein
that are not defined herein shall have the meanings ascribed to them in the respective Supplements
or the Agreement, as the case may be.

ARTICLE II

AMENDMENTS TO SUPPLEMENTS

          SECTION 2.01. Amendment to Section 5.02(a). Section 5.02(a) of each Supplement shall
be deleted in its entirety and inserted in its place shall be the following, it being understood
that any reference to “Series 200[_]-[_]” shall be read to be a reference to the applicable series
designation:

     (a) On each Distribution Date, the Paying Agent, on behalf of the Trustee, shall
forward to each Series 200[_]-[_] Certificateholder a statement substantially in the form of
Exhibit C-1 to this Supplement prepared by the Servicer and delivered to the Paying
Agent.

          SECTION 2.02. Amendment to Section 5.02(b). Section 5.02(b) of each Supplement shall
be deleted in its entirety and inserted in its place shall be the following:

 

 

     (b) Not later than each Determination Date, the Servicer shall deliver to the Trustee,
the Paying Agent, the Transferors, each Rating Agency and the Collateral Interest Holder (i)
a statement substantially in the form of Exhibit C-1 to this Supplement prepared by
the Servicer and (ii) a certificate of a Servicing Officer substantially in the form of
Exhibit D.

          SECTION 2.03. Amendment to Section 5.02(d). Section 5.02(d) of each Supplement shall
be deleted in its entirety and inserted in its place shall be the following, it being understood
that any reference to “Series 200[_]-[_]” shall be read to be a reference to the applicable series
designation:

     (d) On or before January 31 of each calendar year, beginning with calendar year 2008,
the Paying Agent, on behalf of the Trustee, shall furnish or cause to be furnished to each
Person who at any time during the preceding calendar year was a Series 200[_]-[_]
Certificateholder, a statement substantially in the form of Exhibit C-2 to this
Supplement prepared by the Servicer for such calendar year or the applicable portion thereof
during which such Person was a Series 200[_]-[_] Certificateholder, together with other
information as is required to be provided by an issuer of indebtedness under the Code. Such
obligation of the Servicer shall be deemed to have been satisfied to the extent that
substantially comparable information shall be provided by the Paying Agent pursuant to any
requirements of the Code as from time to time in effect.

          SECTION 2.04. Amendment to Exhibits. Each Supplement shall be amended by deleting
Exhibit C thereto and inserting in its place Exhibit C-1 and Exhibit C-2, which shall be in the
forms attached as Exhibit C-1 and Exhibit C-2, respectively, to this Amendment.

ARTICLE III

MISCELLANEOUS

          SECTION 3.01. Ratification of Supplements. As amended by this Amendment, the
Supplements are in all respects ratified and confirmed and each Supplement, as amended by this
Amendment, shall be read, taken and construed as one and the same instrument.

          SECTION 3.02. Counterparts. This Amendment may be executed in two or more
counterparts, and by different parties on separate counterparts, each of which shall be an
original, but all of which shall constitute one and the same instrument.

          SECTION 3.03. GOVERNING LAW. THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK, WITHOUT REFERENCE TO ITS CONFLICT OF LAW PROVISIONS, AND THE
OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH
SUCH LAWS.

 

 

          SECTION 3.04. Effectiveness. The amendments provided for by this Amendment shall
become effective as of January 1, 2008 upon receipt by the Trustee of the following, each of which
shall be satisfactory to the Trustee in its sole discretion, except as otherwise provided:

               (a) notification in writing from each of Moody’s and Standard & Poor’s to the effect that the
terms of this Amendment will not result in a reduction or withdrawal of the rating of any
outstanding Series or Class to which it is a Rating Agency;

               (b) an Officer’s Certificate from each Transferor addressed and delivered to the Trustee
certifying that this Amendment shall not have an Adverse Effect;

               (c) an Opinion of Counsel from the Servicer to the Trustee substantially in the form of
Exhibit E-1 to the Agreement; and

               (d) counterparts of this Amendment, duly executed by the parties hereto.

 

 

          IN WITNESS WHEREOF, the Transferors, the Servicer and the Trustee have caused this Amendment
to be duly executed by their respective officers as of the day and year first above written.

	 	 	 	 	 
	 	AMERICAN EXPRESS RECEIVABLES

FINANCING CORPORATION II, 

as a Transferor

 	 
	 	By:  
	/s/ Maureen Ryan
 	 
	 	 	Name:  	Maureen Ryan  	 
	 	 	Title:  	President 	 
	 
	 	AMERICAN EXPRESS RECEIVABLES

FINANCING CORPORATION III LLC, 

as a Transferor

 	 
	 	By:  
	/s/ Catherine M. Hogan
 	 
	 	 	Name:  	Catherine M. Hogan  	 
	 	 	Title:  	President 	 
	 
	 	AMERICAN EXPRESS RECEIVABLES

FINANCING CORPORATION IV LLC, 

as a Transferor

 	 
	 	By:  
	/s/ Robert C. Radle
 	 
	 	 	Name:  	Robert C. Radle  	 
	 	 	Title:  	President 	 
	 
	 	AMERICAN EXPRESS TRAVEL RELATED

SERVICES COMPANY, INC., 

as Servicer

 	 
	 	By:  
	/s/ David L. Yowan
 	 
	 	 	Name:  	David L. Yowan  	 
	 	 	Title:  	Senior Vice President 	 
	 
	 	THE BANK OF NEW YORK, 

as Trustee

 	 
	 	By:  
	/s/ Catherine Hughes
 	 
	 	 	Name:  	Catherine M. Hughes  	 
	 	 	Title:  	Assistant Vice President 	 
	 

[Omnibus Amendment to Series Supplements]

 

 

EXHIBIT C-1

FORM OF MONTHLY STATEMENT

AMERICAN EXPRESS CREDIT ACCOUNT MASTER TRUST

SERIES 200[_]-[_]

	 	 	 	 	 	 	 
	A)	 	Information regarding distributions on
the Distribution Date in respect of the Class A
Certificates per $1,000 original certificate principal
amount	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The total amount of
the distribution
	 	$                    
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The amount of the
distribution in respect of Class A Monthly
Interest
	 	$                    
	 	 	 
	 	 	 	 
	 	 	(3)

	 	The amount of the
distribution in respect of Class A Outstanding
Monthly Interest
	 	$                    
	 	 	 
	 	 	 	 
	 	 	(4)

	 	The amount of the
distribution in respect of Class A Additional
Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(5)

	 	The amount of the
distribution in respect of principal of the
Class A Certificates
	 	$                     
	 	 	 
	 	 	 	 
	B)	 	Class A Investor Charge-Offs and
Reimbursement of Class A Investor Charge-Offs	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The total amount of
Class A Investor Charge-Offs
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The amount of Class A
Investor Charge-Offs per $1,000 original
certificate principal amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(3)

	 	The total amount
reimbursed in respect of Class A Investor
Charge-Offs
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(4)

	 	The amount reimbursed
in respect of Class A Investor Charge-Offs per
$1,000 original certificate principal amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(5)

	 	The amount, if any, by
which the outstanding principal balance of the
Class A Certificates exceeds the Class A	 	 

C-1-1

 

	 	 	 	 	 	 	 
	 	 	 

	 	Invested Amount after giving effect to all
transactions on such Distribution Date
	 	$                     
	 	 	 
	 	 	 	 
	C)	 	Information regarding distributions in
respect of the Class B Certificates, per $1,000
original certificate principal amount	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The total amount of
the distribution in respect of Class B
Certificates
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The amount of the
distribution in respect of Class B Monthly
Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(3)

	 	The amount of the
distribution in respect of Class B Outstanding
Monthly Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(4)

	 	The amount of the
distribution in respect of Class B Additional
Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(5)

	 	The amount of the
distribution in respect of principal of the
Class B Certificates
	 	$                     
	 	 	 
	 	 	 	 
	D)	 	Amount of reductions in Class B
Invested Amount pursuant to clauses (c), (d), and (e)
of the definition of Class B Invested Amount on such
Distribution Date	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The amount of
reductions in Class B Invested Amount pursuant
to clauses (c), (d) and (e) of the definition
of Class B Invested Amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The amount of the
reductions in the Class B Invested Amount per
$1,000 original certificate principal amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(3)

	 	The total amount
reimbursed in respect of such reductions in
the Class B Invested Amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(4)

	 	The amount reimbursed
in respect of such reductions in the Class B
Invested Amount, per $1,000 original
certificate principal amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(5)

	 	The amount, if any, by
which the outstanding principal balance of the
Class B Certificates exceeds the Class B	 	 

C-1-2

 

	 	 	 	 	 	 	 
	 	 	 

	 	Invested Amount after giving effect to all
transactions on such Distribution Date
	 	$                     
	 	 	 
	 	 	 	 
	E)	 	Information regarding distributions on
the Distribution Date to the Collateral Interest Holder	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The total amount
distributed to the Collateral Interest Holder
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The amount of the
distribution in respect of Collateral Minimum
Monthly Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(3)

	 	The amount of the
distribution in respect of Collateral
Additional Interest
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(4)

	 	The amount distributed
to the Collateral Interest Holder in respect
of principal on the Collateral Invested Amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(5)

	 	The amount of the
distribution to the Collateral Interest Holder
in respect of remaining Excess Spread
	 	$                     
	 	 	 
	 	 	 	 
	F)	 	Amount of reductions in Collateral
Invested Amount pursuant to clauses (c), (d), and (e)
of the definition of Collateral Invested Amount	 	 
	 	 	 
	 	 	 	 
	 	 	(1)

	 	The amount of
reductions in the Collateral Invested Amount
pursuant to clauses (c), (d) and (e) of the
definition of Collateral Invested Amount
	 	$                     
	 	 	 
	 	 	 	 
	 	 	(2)

	 	The total amount
reimbursed in respect of such reductions in
the Collateral Invested Amount
	 	$                     

C-1-3

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	TRUST	 	 	 	 	 	 	 	 	 	 	 	 	 
	TRUST ACTIVITY	 	TOTALS	 	 	 	 	 	 	 	 	 	 	 	 	 
	Record Date
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Number of days in Monthly Period
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Beginning Number of Accounts
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Beginning
Principal Receivable Balance, including any Addition or Removal of Principal Receivables during the Monthly Period
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	a. Addition of the Principal Receivables
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	b. Removal of the Principal Receivables
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Special Funding Account Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Beginning Total Principal Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Finance Charge Collections (excluding Recoveries)
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Recoveries
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total Collections of Finance Charge Receivables
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total Collections of Principal Receivables
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Monthly Payment Rate
	 	 	   	%	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Defaulted Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Annualized Default Rate
	 	 	   	%	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Trust Portfolio Yield
	 	 	  	%	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	New Principal Receivables
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Number of Accounts
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Principal Receivables Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Required Minimum Principal Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Transferor Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Special Funding Account Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Total Principal Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	SERIES ALLOCATIONS
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Group Number
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Invested Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Adjusted Invested Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Principal Funding Account Balance
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Required Transferor Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Allocation Percentage
	 	 	  	%	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Allocable Finance Charge Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Allocable Recoveries
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Allocable Principal Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Allocable Defaulted Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	GROUP ALLOCATIONS
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Group Number
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

C-1-4

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 		 	 	 	 	 	 	 	 	 	 	 	 	 
	GROUP ALLOCATIONS	 		 	 	 	 	 	 	 	 	 	 	 	 	 
	Invested Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Finance Charge Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Monthly Interest
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Default Amount
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Monthly Fees
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Additional Amounts
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Reallocated Investor Finance Charge Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Investment Funding Account Proceeds
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Available Excess
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Group Investor Finance Charge Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Group Expenses
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Group Reallocable Investor Finance Charge Collections
	 	$	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

TRUST PERFORMANCE

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Delinquencies	 	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	31-60 Days Delinquent
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	61-90 Days Delinquent
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	90+ Days Delinquent
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Total 30+ Days Delinquent
	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	TOTAL	 	 	 	 	 	 	 	 
	INVESTOR/TRANSFEROR	 	SERIES	 	 	INVESTOR	 	 	TRANSFERORS’	 	 	 	 	 
	ALLOCATIONS	 	ALLOCATIONS	 	 	INTEREST	 	 	INTEREST	 	 	 	 	 
	Beginning Invested Amount/Transferor Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Beginning Adjusted Invested Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Floating Allocation Percentage
	 	 	     	%	 	 	    	%	 	 	   	%	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Principal Allocation Percentage
	 	 	     	%	 	 	    	%	 	 	   	%	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Collections of Finance Charge Receivables
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Collections of Principal Receivables
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 

C-1-5

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	TOTAL	 	 	 	 	 	 	 	 
	INVESTOR/TRANSFEROR	 	SERIES	 	 	INVESTOR	 	 	TRANSFERORS’	 	 	 	 	 
	ALLOCATIONS	 	ALLOCATIONS	 	 	INTEREST	 	 	INTEREST	 	 	 	 	 
	Defaulted Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ending Invested Amount/Transferor Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	MONTHLY PERIOD	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	FUNDING	 	 	 	 	 	 	 	 	 	COLLATERAL	 	 	 	 
	REQUIREMENTS	 	CLASS A	 	 	CLASS B	 	 	INTEREST	 	 	TOTAL	 
	Principal Funding Account Balance
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Investment Proceeds for Monthly Period
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Reserve Account Opening Balance
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Reserve Account Deposit
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Reserve Draw Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Reserve Account Surplus
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Reserve Account Closing Balance
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	LIBOR Determination Date
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Coupon (__/__/__ to __/__/__)
	 	 	     	%	 	 	    	%	 	 	   	%	 	 	   	%
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Monthly Interest Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Outstanding Monthly Interest Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Additional Interest Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Total Interest Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Default Amount
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Monthly Fees Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Investor Additional Amounts Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	Total Due
	 	$	 	 	 	$	 	 	 	$	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Reallocated Investor Finance Charge Collections
	 	 	 	 	 	 	 	 	 	 	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Interest and Principal Funding Investment Proceeds
	 	 	 	 	 	 	 	 	 	 	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Interest on Reserve Account
	 	 	 	 	 	 	 	 	 	 	 	 	 	$	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Series Adjusted Portfolio Yield
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  	%
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Base Rate
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  	%
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Excess Spread Percentage
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  	%
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

C-1-6

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	COLLATERAL	 	 	 	 
	CERTIFICATES – BALANCES AND DISTRIBUTIONS	 	CLASS A	 	 	CLASS B	 	 	INTEREST	 	 	TOTAL	 
	Beginning Certificates Balance
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	Distributions of Interest
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	Deposits to the Principal Funding Account
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	Distributions of Principal
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	Total Distributions
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	Ending Certificates Balance
	 	$	____________	 	 	$	____________	 	 	$	____________	 	 	$	____________	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	APPLICATION OF REALLOCATED INVESTOR FINANCE CHARGE COLLECTIONS
	1. CLASS A AVAILABLE FUNDS	 	 	 	 	 	 	 	 	 	 	 	 
	a. Class A Monthly Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	b. Class A Outstanding Monthly Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	c. Class A Additional Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	d. Class A Investor Default Amount (treated as
Available Principal Collections)
	 	 	 	 	 	$	____________	 	 	 	 	 
	e. Excess Spread
	 	 	 	 	 	$	____________	 	 	 	 	 
	2. CLASS B AVAILABLE FUNDS	 	 	 	 	 	 	 	 	 	 	 	 
	a. Class B Monthly Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	b. Class B Outstanding Monthly Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	c. Class B Additional Interest
	 	 	 	 	 	$	____________	 	 	 	 	 
	d. Excess Spread
	 	 	 	 	 	$	____________	 	 	 	 	 
	3. COLLATERAL AVAILABLE FUNDS	 	 	 	 	 	 	 	 	 	 	 	 
	a. Excess Spread
	 	 	 	 	 	$	____________	 	 	 	 	 
	4. TOTAL EXCESS SPREAD	 	 	 	 	 	$	____________	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	REALLOCATED PRINCIPAL COLLECTIONS	 	 	 	 	 	 	 	 	 	 	 	 
	1. Principal Allocation Percentage	 	 	 	 	 	 	____________	%	 	 	 	 
	2. Series 200[_]-[_] Allocable Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	3. Principal Allocation Percentage of Series
200[_]-[_] Allocable Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	4. Reallocated Principal Collections Required to fund the Required Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	5. Item 3 minus Item 4	 	 	 	 	 	$	____________	 	 	 	 	 
	6. Shared Principal Collections from other Series allocated to Series 200[_]-[_]	 	 	 	 	 	$	____________	 	 	 	 	 
	7. Other amounts treated as Available Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	8. Available Principal Collections (total of items 5, 6 and 7)	 	 	 	 	 	$	____________	 	 	 	 	 

C-1-7

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	APPLICATION OF AVAILABLE PRINCIPAL COLLECTIONS DURING REVOLVING PERIOD
	1. Collateral Invested Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	2. Required Collateral Invested Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	3. Excess of Collateral Invested Amount over Required Collateral Invested Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	4. Treated as Shared Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	APPLICATION OF PRINCIPAL COLLECTIONS DURING ACCUMULATION OR AMORTIZATION PERIOD
	1. Principal Funding Account	 	 	 	 	 	$	____________	 	 	 	 	 
	2. Excess of Collateral Invested Amount over Required Collateral Invested Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	3. Distribution of Principal	 	 	 	 	 	$	____________	 	 	 	 	 
	4. Treated as Shared Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	APPLICATION OF EXCESS SPREAD AND
EXCESS FINANCE CHARGE COLLECTIONS ALLOCATED TO SERIES 200[_]-[_]
	1. Excess Spread	 	 	 	 	 	$	____________	 	 	 	 	 
	2. Excess Finance Charge Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	3. Applied to fund Class A Required Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	4. Class A Investor Charge-Offs treated as Available Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	5. Applied to fund overdue Class B Interest	 	 	 	 	 	$	____________	 	 	 	 	 
	6. Applied to fund Class B Required Amount	 	 	 	 	 	$	____________	 	 	 	 	 
	7. Reduction of Class B Invested Amount treated as Available Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	8. Applied to Collateral Minimum Monthly Interest	 	 	 	 	 	$	____________	 	 	 	 	 
	9. Applied to unpaid Monthly Servicing Fee	 	 	 	 	 	$	____________	 	 	 	 	 
	10. Collateral Default Amount treated as Available Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	11. Reduction of Collateral Invested Amount treated as Available Principal Collections	 	 	 	 	 	$	____________	 	 	 	 	 
	12. Deposited to Reserve Account	 	 	 	 	 	$	____________	 	 	 	 	 
	13. Remaining Excess Spread distributed to Collateral Interest Holder(s)	 	 	 	 	 	$	____________	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	YIELD AND BASE RATE	 	 	 	 	 	 	 	 	 	 	 	 
	1. Base Rate	 	 	 	 	 	 	 	 	 	 	 	 
	Current Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 

C-1-8

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	YIELD AND BASE RATE	 	 	 	 	 	 	 	 	 	 	 	 
	Prior Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 
	Second Prior Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 
	2. Three Month Average Base Rate	 	 	 	 	 	 	____________	%	 	 	 	 
	3. Series Adjusted Portfolio Yield	 	 	 	 	 	 	 	 	 	 	 	 
	Current Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 
	Prior Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 
	Second Prior Monthly Period
	 	 	 	 	 	 	 	 	 	 	____________	%	 	 	 	 
	4. Three Month average Series Adjusted Portfolio Yield	 	 	 	 	 	 	____________	%	 	 	 	 
	5. Is the 3 month average Series Adjusted Portfolio
Yield more than the 3 month average Base Rate?
	 	 	 	 	 	[Yes/No]	 	 	 	 

C-1-9

 

EXHIBIT C-2

FORM OF ANNUAL PAYMENT INFORMATION

AMERICAN EXPRESS CREDIT ACCOUNT MASTER TRUST

SERIES 200[_]-[_]

FOR THE YEAR ENDED DECEMBER 31, 200[_]

     The undersigned, a duly authorized representative of American Express Travel Related Services
Company, Inc. (“TRS”), as Servicer pursuant to the Pooling and Servicing Agreement, dated as of May
16, 1996, as amended and restated as of January 1, 2006 (as amended and restated and as otherwise
amended and supplemented, the “Pooling and Servicing Agreement”), among TRS, American Express
Receivable Financing Corporation II, American Express Receivable Financing Corporation III LLC and
American Express Receivable Financing Corporation IV LLC, as transferors (together, the
“Transferors”) and The Bank of New York, as trustee (the “Trustee”), does hereby certify as
follows:

     Capitalized terms used in this Certificate have their respective meanings set forth in the
Pooling and Servicing Agreement or the Series 200[_]-[_] Supplement, dated as of [                    ], 200[_],
among TRS, the Transferors and the Trustee (as amended and supplemented, the “Supplement”), as
applicable.

     Pursuant to Section 5.01 of the Series Supplement, the Servicer instructed the Trustee to pay
in accordance with Section 5.01 from the Interest Funding Account or the Principal Funding Account,
as applicable, the following aggregate amounts during the year ended December 31, 200[_]:

	 	 	 	 	 	 	 
	A)
	 	Pursuant to subsection 5.01(a):	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	Interest distributed to Class A Certificateholders	 	$	               	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	B)
	 	Pursuant to subsection 5.01(b):	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	On the Expected Final Payment Date or a Special	 	 	 	 
	 
	 	Payment Date, if applicable, principal distributed	 	 	 	 
	 
	 	to the Class A Certificateholders	 	$	 	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	C)
	 	Pursuant to subsection 5.01(c):	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	Interest distributed to Class B Certificateholders	 	$	 	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	D)
	 	Pursuant to subsection 5.01(d):	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	On the Expected Final Payment Date or a Special	 	 	 	 
	 
	 	Payment Date, if applicable, on or after the date	 	 	 	 
	 
	 	Class A Invested Amount is paid in full, principal	 	 	 	 
	 
	 	distributed to the Class B Certificateholders	 	$	 	 
	 
	 	 	 	 	 

C-2-1

 

	 	 	 	 	 	 	 
	E)
	 	Pursuant to subsection 5.01(e):	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	Aggregate amount distributed to the Collateral	 	 	 	 
	 
	 	Interest Holder in respect of interest	 	$	               	 
	 
	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	Aggregate amount distributed to the Collateral	 	 	 	 
	 
	 	Interest Holder in respect of principal	 	$	 	 
	 
	 	 	 	 	 

IN WITNESS WHEREOF, the undersigned has duly executed this Certificate this [_] day of January,
200[_].

	 	 	 	 	 
	 	AMERICAN EXPRESS TRAVEL RELATED 

SERVICES COMPANY, INC., as Servicer

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

C-2-2EX-4.11

 

Exhibit 4.11

JAVELIN PHARMACEUTICALS, INC.

AMENDED AND RESTATED

2005 OMNIBUS STOCK INCENTIVE PLAN

     This 2005 Omnibus Stock Incentive Plan, as amended and restated (the “Plan”), is
established by Javelin Pharmaceuticals, Inc., a Delaware corporation (the “Company”),
effective as of July 28, 2005 (the “Effective Date”), and may be amended from time to time.

     1. Purpose. The Plan is intended to provide qualifying Employees, Directors and
Consultants with equity ownership in the Company and its Subsidiaries, thereby strengthening their
commitment to the success of the Company, promoting the identity of interests between the Company’s
shareholders and such Employees, Directors and Consultants and stimulating their efforts on behalf
of the Company, and to assist the Company in attracting and retaining talented personnel.

     2. Scope of the Plan. Subject to adjustment as set forth in accordance with Section
22, the total number of Shares which may be issued pursuant to Awards under the Plan is 9,000,000,
and to the extent consistent with Section 424 of the Code, such Shares may be issued under ISOs. In
accordance with the requirements of Section 162(m) of the Code, the number of Shares for which
Awards may be granted to any individual Grantee in any calendar year shall not exceed 1,000,000. If
any Shares subject to any Award granted hereunder are forfeited or such Award otherwise terminates
without the issuance of such Shares or for other consideration in lieu of such Shares, the Shares
subject to such Award, to the extent of any such forfeiture or termination, shall again be
available for grant under the Plan. If any outstanding ISOs under the Plan for any reason expire or
are terminated, the Shares allocable to the unexercised portion of all of such ISOs may again be
subject to the ISOs under the Plan. Shares awarded under the Plan may be treasury shares or
newly-issued shares.

     3. Administration.

          (a) Committee. Except with respect to Section 7 below (Automatic Option Grants), the
Plan shall be administered by a Committee which shall consist of at least two or more members of
the Board, all of whom, may qualify as “outside directors” as defined for purposes of the
regulations under Section 162(m) of the Code and as “on-Employee directors” under Section (b)(3)(i)
of Rule 16b-3. Upon listing the Shares on any national securities exchange or the Nasdaq system,
the members of the Committee must then also meet the requirements of any such exchange or NASDAQ
system. The number of members of the Committee shall from time to time be increased or decreased,
and shall be subject to such conditions, in each case as the Board deems appropriate to permit
transactions in Shares pursuant to the Plan to satisfy such conditions of Rule 16b-3 and Section
162(m) of the Code as then in effect. Notwithstanding anything to the contrary in this Plan, the
Committee may be comprised of the entire Board. The Automatic Option Grant Program described in
Section 7 below shall be self-executing in accordance with its terms, and the Committee shall not
exercise any discretionary authority with respect to any grants made under that program.

          (b) Authority. Subject to the express provisions of the Plan, the Committee has full
and final authority and discretion as follows:

               (i) to determine when and to whom Awards should be granted and the terms, conditions and
restrictions applicable to each Award, including, without limitation, (A) the exercise price of the
Award, (B) the method of payment for Shares purchased upon the exercise of the Award, (C) the
method of satisfaction of any tax withholding obligation arising in connection with the Award, (D)
the timing, terms and conditions of the exercisability of the Award or the vesting of any Shares
acquired upon the exercise thereof, (E) the time of the expiration of the vesting of any Shares
acquired upon the exercise thereof, (F) the effect of the Grantee’s termination of employment or
service with the Company on any of the foregoing, (G) all other terms, conditions and restrictions
applicable to the Award or such Shares not inconsistent with the terms of the Plan, (H) the benefit
payable under any SAR or Performance Share, and (I) whether or not specific Awards shall be
identified with other specific Awards, and if so whether they shall be exercisable cumulatively
with, or alternatively to, such other specific Awards;

               (ii) to determine the amount, if any, that a Grantee shall pay for Restricted Shares, whether
to permit or require the payment of cash dividends thereon to be deferred and the terms related
thereto, when Restricted Shares (including Restricted Shares acquired upon the exercise of any
Award) shall be forfeited and whether such Shares shall be held in escrow;

               (iii) to interpret the Plan and to make all determinations necessary or advisable
for the administration of the Plan;

 

 

               (iv) to make, amend and rescind rules, guidelines and policies relating to the Plan, or to
adopt supplements to, or alternative versions of the Plan, including, without limitation, rules
with respect to the exercisability and forfeitability of Awards upon the termination of employment
or service of a Grantee;

               (v) to determine the terms, conditions and restrictions of all Award Agreements (which need
not be identical) and, with the consent of the Grantee, to amend any such Award Agreement at any
time, among other things, to permit transfers of such Awards to the extent permitted by the Plan,
except that the consent of the Grantee shall not be required for any amendment which (A) does not
adversely affect the rights of the Grantee or (B) is necessary or advisable (as determined by the
Committee) to carry out the purpose of the Award as a result of any change in applicable law;

               (vi) to cancel, with the consent of the Grantee, outstanding Awards and to grant new Awards in
substitution therefor;

               (vii) to accelerate the exercisability of, and to accelerate or waive any or all of the terms,
conditions and restrictions applicable to, any Award or any group of Awards for any reason and at
any time, including in connection with a termination of employment (other than for Cause);

               (viii) subject to Section 6(c), to extend the time during which any Award or group
of Awards may be exercised;

               (ix) to have the Award either comply with Section 409A of the Code or not result in the
deferral of compensation within the meaning of said Section 409A;

               (x) to make such adjustments or modifications to Awards to Grantees working outside the United
States as are advisable to fulfill the purposes of the Plan;

               (xi) to impose such additional terms, conditions and restrictions upon the grant, exercise or
retention of Awards as the Committee may, before or concurrent with the grant thereof, deem
appropriate; and

               (xii) to take any other action with respect to any matters relating to the Plan for
which it is responsible.

The determination of the Committee on all matters relating to the Plan or any Award Agreement shall
be final.

     4. Indemnification and Reimbursement. Service as a member of the Committee or any
other duly appointed committee shall constitute service as a Board member, and such members shall
accordingly be entitled to full indemnification and reimbursement as Board members for their
service as members of the Committee or any other duly appointed committee. Neither he Committee nor
any duly appointed committee member shall be liable for any act or omission made in good faith with
respect to the Plan or any Award granted under the Plan.

     5. Eligibility. The Committee may, in its discretion, grant Awards to any Eligible
Person, whether or not he or she has previously received an Award, except in the case of (a) an
ISO, which can only be granted to an Employee of the Company or any Subsidiary and (b) the
Automatic Option Grant Program described in Section 7 below, which shall be self-executing. The
individuals who shall be eligible to participate in the Automatic Option Grant Program shall be
limited to(i) those individuals who first become non-employee Directors, whether through
appointment by the Board or election by the Company’s stockholders, and (ii) those individuals who
continue to serve as non-employee Directors. A non-employee Director who has previously been
employed by the Company (or any parent or Subsidiary) shall not be eligible to receive an option
grant under the Automatic Option Grant Program at the time he or she first becomes a non-employee
Director, but shall be eligible to receive periodic option grants under the Automatic Option Grant
Program while he or she continues to serve as a non-employee Director.

     6. Conditions to Grants.

          (a) General Conditions. Awards shall be evidenced by written Award Agreements
specifying the number of Shares covered thereby, in such form as the Committee shall from time to
time establish. To the extent consistent with Section 3(b), Award Agreements may incorporate all or
any of the terms of the Plan by reference and shall comply with and be subject to the following
terms and conditions:

2

 

               (i) The Grant Date of an Award shall be the date on which the Committee grants the Award or
such later date as specified in advance by the Committee;

               (ii) In the case of an Award of options, the Option Term shall under no circumstances extend
more than ten (10) years after the Grant Date and shall be subject to earlier termination as herein
provided and as provided in the applicable Award Agreement; and

               (iii) Any terms and conditions of an Award not set forth in the Plan shall be set forth in the
Award Agreement related to that Award.

          (b) Grant of Options. No later than the Grant Date of any option, the Committee shall
determine the Option Price of such option. Subject to Section 6(c), the Option Price of an option
may be not less than the Fair Market Value of a Share on the Grant Date. An option shall be
exercisable for unrestricted Shares, unless the Award Agreement provides that it is exercisable for
Restricted Shares.

          (c) Grant of ISOs. At the time of the grant of any option, the Committee may, in its
discretion, designate that such option shall be made subject to additional restrictions to permit
the option to qualify as an “incentive stock option” under the requirements of Section 422 of the
Code. Any option designated as an ISO:

               (i) shall have an Option Price that is not less than the Fair Market Value of a Share on the
Grant Date and, if granted to a Ten Percent Owner, have an Option Price that is not less than 110%
of the Fair Market Value of a Share on the Grant Date;

               (ii) shall be for a period of not more than ten (10) years and, if granted to a Ten Percent
Owner, not more than five (5) years, from the Grant Date and shall be subject to earlier
termination as provided herein or in the applicable Award Agreement;

               (iii) shall meet the limitations of this subparagraph 6(c)(iii). If the aggregate Fair Market
Value of Shares with respect to which ISOs first become exercisable by a Grantee in any calendar
year exceeds the limit determined in accordance with the provisions of Section 422 of the Code (the
“Limit”) taking into account Shares subject to all ISOs granted by the Company which are
held by the Grantee, the excess will be treated as nonqualified options. To determine whether the
Limit is exceeded, the Fair Market Value of Shares subject to options shall be determined as of the
Grant Dates of the options. In reducing the number of options treated as ISOs to meet the Limit,
the most recently granted options will be reduced first. If a reduction of simultaneously granted
options is necessary to meet the Limit, the Committee may designate which Shares are to be treated
as Shares acquired pursuant to an ISO;

               (iv) shall be granted within ten (10) years from the Effective Date;

               (v) shall require the Grantee to notify the Committee of any disposition of any Shares issued
upon the exercise of the ISO under the circumstances described in Section 421(b) of the Code
(relating to certain disqualifying dispositions, a “Disqualifying Disposition”), within ten
(10) business days after such Disqualifying Disposition; and

               (vi) unless otherwise permitted by the Code, shall by its terms not be assignable or
transferable other than by will or by the laws of descent and distribution and may be exercised,
during the Grantee’s lifetime, only by the Grantee, except that the Grantee may, in accordance with
Section 7, designate in writing a beneficiary to exercise his or her ISOs after the Grantee’s
death.

          (d) Grant of SARs.

               (i) When granted, SARs may, but need not, be identified with a specific option, specific
Restricted Shares or specific Performance Shares of the Grantee (including any option, Restricted
Shares or Performance Shares granted on or before the Grant Date of the SARs) in a number equal to
or different from the number of SARs so granted. If SARs are identified with Shares subject to an
option, with Restricted Shares or with Performance Shares, then, unless otherwise provided in the
applicable Award Agreement, the Grantee’s associated SARs shall terminate upon (A) the expiration,
termination, forfeiture, or cancellation of such option, Restricted Shares or Performance Shares,
(B) the exercise of such option or Performance Shares or(C) the date such Restricted Shares become
nonforfeitable.

               (ii) The Strike Price of any SAR shall equal, for any SAR that is identified with an option,
the Option Price of such option, or for any other SAR, one hundred percent (100%) of the Fair
Market Value of a Share on the Grant Date of such SAR, except

3

 

that the Committee may (A) specify a higher Strike Price in the Award Agreement or (B) provide that
the benefit payable upon exercise of any SAR shall not exceed such percentage of the Fair Market
Value of a Share on such Grant Date as the Committee shall specify.

          (e) Grant of Performance Shares.

               (i) Before the grant of Performance Shares, the Committee shall:

                    (A) determine objective performance goals, which may, but need not, consist of any one or more
of the following goals deemed appropriate by the Committee: certain scientific milestones, earnings
(either in the aggregate or on a per share basis), operating income, cash flow, EBITDA (earnings
before interest, taxes, depreciation and amortization),return on equity, indices related to EVA
(economic value added), per share rate of return on the Common Stock (including dividends), market
share (in one or more markets), customer retention rates, market penetration rates, revenues,
reductions in expense levels and the attainment by the Common Stock of a specified market value for
a specified period of time, in each case where applicable to be determined either on a company-wide
basis or in respect of any one or more business units, and the amount of compensation under the
goals applicable to such grant;

                    (B) designate a period for the measurement of the extent to which performance goals are
attained, which may begin prior to the Grant Date (the “Performance Period”); and

                    (C) assign a performance percentage to each level of attainment of performance goals during
the Performance Period, with the percentage applicable to minimum attainment being zero percent and
the percentage applicable to maximum attainment to be determined by the Committee from time to time
(the “Performance Percentage”).

               (ii) If a Grantee is promoted, demoted, or transferred to a different business unit of the
Company during a Performance Period, then, to the extent the Committee determines any one or more
of the performance goals, Performance Period, or Performance Percentage are no longer appropriate,
the Committee may make any changes thereto as it deems appropriate in order to make them
appropriate.

               (iii) When granted, Performance Shares may, but need not, be identified with Shares subject to
a specific option, specific Restricted Shares, or specific SARs of the Grantee granted under the
Plan in a number equal to or different from the number of the Performance Shares so granted. If
Performance Shares are so identified, then, unless otherwise provided in the applicable Award
Agreement, the Grantee’s associated Performance Shares shall terminate upon (A) the expiration,
termination, forfeiture, or cancellation of the option, Restricted Shares, or SARs with which the
Performance Shares are identified, (B) the exercise of such option or SARs or (C) the date
Restricted Shares become nonforfeitable.

          (f) Grant of Restricted Shares.

               (i) The Committee shall determine the amount, if any, that a Grantee shall pay for Restricted
Shares, subject to the following sentence. Except with respect to Restricted Shares that are
treasury shares, for which no payment need be required, the Committee shall require the Grantee to
pay at least the Minimum Consideration for each Restricted Share. Such payment shall be made in
full by the Grantee before the delivery of the shares and in any event no later than ten (10)
business days after the Grant Date.

               (ii) The Committee may, but need not, provide that all or any portion of a Grantee’s
Restricted Shares, or Restricted Shares acquired upon exercise of an option, shall be forfeited:

                    (A) except as otherwise specified in the Plan or the Award Agreement, upon the termination of
Grantee’s employment with, or Service to, the Company within a specified time period after the
Grant Date;

                    (B) if the Company or the Grantee does not achieve specified performance goals (if any)within
a specified time period after the Grant Date and before the Grantee’s termination of employment or
service; or

                    (C) upon failure to satisfy such other conditions, or Grantee’s breach of specific conditions,
as the Committee may specify in the Award Agreement.

               (iii) If Restricted Shares are forfeited and the Grantee was required to pay for
such shares or acquired such

4

 

Restricted Shares upon the exercise of an option, the Grantee shall be deemed to have resold such
Restricted Shares to the Company at a price equal to the lesser of (A) the amount paid by the
Grantee for such Restricted Shares and (B) the Fair Market Value of the Restricted Shares on the
date of forfeiture, which shall be paid to the Grantee in cash as soon as administratively
practicable. Such Restricted Shares shall cease to be outstanding and shall no longer confer on the
Grantee thereof any rights as a shareholder of the Company, from and after the date of the event
causing the forfeiture, whether or not the Grantee accepts the Company’s tender of payment for such
Restricted Shares.

               (iv) The Committee may provide that the certificates for any Restricted Shares (A) shall be
held(together with a stock power executed in blank by the Grantee) in escrow by the Secretary of
the Company until such Restricted Shares become nonforfeitable or are forfeited or (B) shall bear
an appropriate legend restricting the transfer of such Restricted Shares. If any Restricted Shares
become nonforfeitable, the Company shall cause certificates for such shares to be issued without
such legend.

          (g) Grant of Stock Bonuses. The Committee may grant Bonus Shares to any
Eligible Person.

     7. Automatic Option Grant Program
..

          (a) Option Terms.

               (i) Grant Dates. Option grants shall be made on the dates specified below:

                    (A) Each individual who is first elected or appointed as a non-employee Director shall
automatically be granted, on the date of such initial election or appointment, a non-statutory
option to purchase 50,000 Shares, provided that individual has not been in the employment of the
Company or any parent or Subsidiary within two (2) years prior to becoming a non-employee Director.

                    (B) In the first quarter of the calendar year immediately following the calendar year in which
an individual is first elected or appointed as a non-employee Director, and each year thereafter
that he or she remains anon-employee Director, he or she shall automatically be granted an annual
non-statutory option to purchase 25,000 Shares. This automatic annual grant may be awarded on a
triennial basis for the purchase of 75,000 Shares, provided that no annual automatic grant shall be
made to such non-employee Director for each of the two (2) succeeding years. Further, in
consideration of each year’s service on a committee of the Board, a non-employee Director shall
automatically be granted a non-statutory option for the purchase of 5,000 Shares for serving on one
or more committees of the Board, plus (i) an additional 5,000 Shares for each committee (other than
the Audit Committee) for which he or she serves as the chair thereof, and an additional 10,000
Shares for serving as chair of the Audit Committee and (ii) an additional 20,000 Shares for serving
as Chairman of the Board. There shall be no limit on the number of such share option grants, as
applicable, any one non-employee Director may receive over his or her period of Board service.
Non-employee Directors who have previously been in the employment of the Company (or any parent or
Subsidiary) or who have otherwise received one or more stock option grants from the Company prior
to the date on which such person first became a non-employee Director shall be eligible to receive
one or more such annual option grants over their period of continued Board service as provided
herein.

               (ii) Exercise Price.

                    (A) The exercise price per share shall be equal to one hundred percent (100%) of the Fair
Market Value per Share on the option grant date.

                    (B) The exercise price shall be payable as set forth in Section 9 below.

               (iii) Option Term. Each option shall have a term of ten (10) years measured
from the option grant date.

               (iv) Exercise and Vesting of Options. The Shares subject to the options granted to the
non-employee Directors pursuant to this Section 7 shall vest in one installment upon the optionee’s
completion of the one (1)-year period of service measured from the grant date, provided that Shares
subject to options granted on a triennial basis shall vest one-third a year after one (1) year and
the optionee is in continued Board service on the vesting date, subject to clause (vi) below. Upon
any Shares becoming vested, the option for such Shares shall be immediately exercisable for any or
all of such vested Shares.

               (v) Limited Transferability of Options. Each option under this Section 7 may be
assigned in whole or in part during the optionee’s lifetime to one or more members of the
optionee’s family or to a trust established exclusively for one or more such

5

 

family members or to optionee’s former spouse, to the extent such assignment is in connection with
the optionee’s estate plan or pursuant to a domestic relations order. The assigned portion may only
be exercised by the person or persons who acquire a proprietary interest in the option pursuant to
the assignment. The terms applicable to the assigned portion shall be the same as those in effect
for the option immediately prior to such assignment and shall be set forth in such documents issued
to the assignee as the Committee may deem appropriate. The optionee may also designate one or more
persons as the beneficiary or beneficiaries of his or her outstanding options under this Section 7,
and those options shall, in accordance with such designation, automatically be transferred to such
beneficiary or beneficiaries upon the optionee’s death while holding those options. Such
beneficiary or beneficiaries shall take the transferred options subject to all the terms and
conditions of the applicable agreement evidencing each such transferred option, including (without
limitation) the limited time period during which the option may be exercised following the
optionee’s death.

               (vi) Termination of Board Service. The following provisions shall govern the exercise of any
options held by the optionee at the time the optionee ceases to serve as a Director:

                    (A) The optionee (or, in the event of optionee’s death, the personal representative of the
optionee’s estate or the person or persons to whom the option is transferred pursuant to the
optionee’s will or the laws of inheritance or the designated beneficiary or beneficiaries of such
option) shall have a eighteen (18)-month period following the date of such cessation of Board
service in which to exercise each such option.

                    (B) During the eighteen (18)-month exercise period, the option may not be exercised in the
aggregate for more than the number of vested Shares for which the option is exercisable at the time
of the optionee’s cessation of Board service.

                    (C) Should the optionee cease to serve as a Director by reason of death or Disability, then
all shares at the time subject to the option shall immediately vest so that such option may, during
the eighteen (18)-month exercise period following such cessation of Board service, be exercised for
any or all of those shares as fully vested Shares.

                    (D) In no event shall the option remain exercisable after the expiration of the option term.
Upon the expiration of the eighteen (18)-month exercise period or (if earlier) upon the expiration
of the option term, the option shall terminate and cease to be outstanding for any vested shares
for which the option has not been exercised. However, the option shall, immediately upon the
optionee’s cessation of Board service for any reason other than death or Disability, terminate and
cease to be outstanding to the extent the option is not otherwise at that time exercisable for
vested shares.

          (b) Corporate Transaction.

               (i) In the event of a Corporation Transaction (as described in Section 13 below) while the
optionee remains a Director, the Shares at the time subject to each outstanding option held by such
optionee under this Automatic Option Grant Program but not otherwise vested shall automatically
vest in full so that each such option shall, immediately prior to the effective date of the
Corporate Transaction, become exercisable for all the option shares as fully vested Shares and may
be exercised for any or all of those vested shares. Immediately following the consummation of the
Corporate Transaction, each automatic option grant shall terminate and cease to be outstanding,
except to the extent assumed by the successor corporation (or parent thereof) or otherwise
continued in effect pursuant to the terms of the Corporate Transaction.

               (ii) In the event of a Corporate Transaction, all outstanding repurchase rights under this
under this Automatic Option Grant Program shall automatically terminate, and the Shares subject to
those terminated rights shall immediately vest in full.

               (iii) Upon the occurrence of a Hostile Tender-Offer while the optionee remains a Director,
such optionee shall have a thirty (30)-day period in which to surrender to the Company each of his
or her outstanding options under this Automatic Option Grant Program. The optionee shall in return
be entitled to a cash distribution from the Company in an amount equal to the excess of (i) the
Tender-Offer Price of the Shares at the time subject to each surrendered option (whether or not the
optionee is otherwise at the time vested in those shares) over (ii) the aggregate exercise price
payable for such shares. Such cash distribution shall be paid within five (5) days following the
surrender of the option to the Company. No approval or consent of the Board or any Committee shall
be required at the time of the actual option surrender and cash distribution.

               (iv) Each option which is assumed in connection with a Corporate Transaction or otherwise
continued in effect shall be appropriately adjusted, immediately after such Corporate
Transaction, to apply to the number and class of securities which would have been issuable to
the optionee in consummation of such Corporate Transaction had the option been exercised
immediately prior to such Corporate Transaction. Appropriate adjustments shall also be made to the
exercise price payable per share under each

6

 

outstanding option, provided the aggregate exercise price payable for such securities shall remain
the same. To the extent the actual holders of the Company’s outstanding Common Stock receive cash
consideration for their Common Stock in consummation of the Corporate Transaction, the successor
corporation may, in connection with the assumption of the outstanding options under the Automatic
Option Grant Program, substitute one or more shares of its own common stock with a fair market
value equivalent to the cash consideration paid per share of Common Stock in such Corporate
Transaction.

               (v) The grant of options under the Automatic Option Grant Program shall in no way affect the
right of the Company to adjust, reclassify, reorganize or otherwise change its capital or business
structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its
business or assets.

          (c) Remaining Terms. The remaining terms of each option granted under the Automatic Option
Grant Program shall be the same as the terms in effect for other option grants made under the Plan.

     8. Transferability. Notwithstanding any contrary provision in the Plan, all Awards granted
hereunder, other than ISOs, may be assigned or transferred by Grantee to (i) one or more members of
Grantee’s Immediate Family; (ii) trusts for the benefit of the Grantee and/or Grantee’s Immediate
Family; (iii) entities wholly-owned by Grantee and/or Grantee’s Immediate Family; (iv) charitable
institutions; or (v) Grantee’s estate or any person who acquires the right to exercise this Option
by bequest or inheritance or by reason of Grantee’s death, by will or by the laws of descent and
distribution. Subject to Section 6(c) in respect of ISOs, a Grantee may, if permitted by the
Committee, in its discretion, (a) designate in writing a beneficiary to exercise an Award after his
or her death (if that designation has been received by the Company prior to the Grantee’s death)
and (b)transfer the Award to one or more members of the Grantee’s Immediate Family or any other
individuals or entities.

     9. Exercise.

          (a) Exercise of Options.

               (i) Subject to Section 6 and except as otherwise provided in the applicable Award Agreement,
each option shall become exercisable at such time or times as may be specified by the Committee
from time to time.

               (ii) An option shall be exercised by the delivery to the Company during the Option Term of (A)
a written notice of intent to purchase a specific number of Shares subject to the option in
accordance with the terms of the option by the person entitled to exercise the option and (B)
payment in full of the Option Price of such specific number of Shares in accordance with Section
8(a)(iii).

               (iii) To the extent not prohibited by Section 402 of the Sarbanes-Oxley Act of 2002, payment
of the Option Price may be made by any one or more of the following means:

                    (A) cash, check, or wire transfer;

                    (B) with the approval of the Committee, Mature Shares, valued at their Fair Market Value on
the date of exercise;

                    (C) with the approval of the Committee, Restricted Shares held by the Grantee for at least
six(6) months prior to the exercise of the option, each such share valued at the Fair Market Value
of a Share on the date of exercise; or

                    (D) in accordance with procedures previously approved by the Company, through the sale of the
Shares acquired on exercise of the option through a bank or broker-dealer to whom the Grantee has
submitted an irrevocable notice of exercise and irrevocable instructions to deliver promptly to the
Company the amount of sale or loan proceeds sufficient to pay for such Shares, together with, if
requested by the Company, the amount of federal, state, local or foreign withholding taxes payable
by Grantee by reason of such exercise.

The Committee may in its discretion specify that, if any Restricted Shares are used to pay the
Option Price (“Tendered Restricted Shares”), (A) all the Shares acquired on exercise of the option
shall be subject to the same restrictions as the Tendered Restricted Shares, determined as of the
date of exercise of the option or (B) a number of Shares acquired on exercise of the option equal
to the number of Tendered Restricted Shares shall be subject to the same restrictions as the
Tendered Restricted Shares, determined as of the date of exercise of the option.

7

 

          (b) Exercise of SARs.

               (i) Subject to Section 6(d), and except as otherwise provided in the applicable Award
Agreement,(A) each SAR not identified with any other Award shall become exercisable with respect to
twenty-five percent (25%) of the Shares subject thereto on each of the first four (4) year
anniversaries of the Grant Date of such SAR and (B) each SAR which is identified with any other
Award shall become exercisable as and to the extent that the Award with which such SAR is
identified may be exercised or becomes nonforfeitable, as the case may be.

               (ii) SARs shall be exercised by delivery to the Company of written notice of intent to
exercise a specific number of SARs. Unless otherwise provided in the applicable Award Agreement,
the exercise of SARs which are identified with Shares subject to an option or Restricted Shares
shall result in the cancellation or forfeiture of such option or Restricted Shares, as the case may
be, to the extent of such exercise.

               (iii) The benefit for each SAR exercised shall be equal to (A) the Fair Market Value of a
Share on the date of such exercise minus (B) the Strike Price specified in such SAR. Such benefit
shall be payable in cash, except that the Committee may provide in the Award Agreement that
benefits may be paid wholly or partly in Shares.

          (c) Payment of Performance Shares. Unless otherwise provided in the Award Agreement with
respect to an Award of Performance Shares, if the minimum performance goals applicable to such
Performance Shares have been achieved during the applicable Performance Period, then the Company
shall pay to the Grantee of such Award that number of Shares equal to the product of:

               (i) the sum of (A) number of Performance Shares specified in the applicable Award Agreement
and(B) the number of Shares that would have been issuable if such Performance Shares had been
Shares outstanding throughout the Performance Period and the stock dividends, cash dividends
(except as otherwise provided in the Award Agreement) and other property paid in respect of such
Shares had been reinvested in additional Shares as of each dividend payment date,

               (ii) the Performance Percentage achieved during such Performance Period.

The Committee may, in its discretion, determine that cash be paid in lieu of some or all of such
Shares. The amount of cash payable in lieu of a Share shall be determined by valuing such Share at
its Fair Market Value on the business day next preceding the date such cash is to be paid. Payments
pursuant to this Section 8 shall be made as soon as administratively practicable after the end of
the applicable Performance Period. Any Performance Shares with respect to which the performance
goals shall not have been achieved by the end of the applicable Performance Period shall expire.

     10. Notification under Section 83(b). If the Grantee, in connection with the exercise of any
option or the grant of Restricted Shares, makes the election permitted under Section 83(b) of the
Code to include in such Grantee’s gross income in the year of transfer the amounts specified in
Section 83(b) of the Code, then such Grantee shall notify the Company, in writing, of such election
within ten (10) days after filing the notice of the election with the Internal Revenue Service, in
addition to any filing and notification required pursuant to regulations issued under Section 83(b)
of the Code. The Committee may, in connection with the grant of an Award or at any time thereafter,
prohibit a Grantee from making the election described in this Section 9.

     11. Mandatory Tax Withholding.

          (a) Whenever under the Plan, Shares are to be delivered upon exercise or payment of an Award
or upon Restricted Shares becoming nonforfeitable, or any other event with respect to rights and
benefits hereunder, the Company shall been titled to require (i) that the Grantee remit an amount
in cash, or in the Company’s discretion, Mature Shares or any other form of consideration,
sufficient to satisfy all federal, state and local tax withholding requirements related thereto
(“Required Withholding”), (ii) the withholding of such Required Withholding from compensation
otherwise due to the Grantee or from any Shares due to the Grantee under the Plan or (iii) any
combination of the foregoing.

          (b) Any Grantee who makes a Disqualifying Disposition or an election under Section 83(b) of
the Code shall remit to the Company an amount sufficient to satisfy all resulting Required
Withholding, except that in lieu of or in addition to the foregoing, the Company shall have the
right to withhold such Required Withholding from compensation otherwise due to the Grantee or from
any Shares or other payment due to the Grantee under the Plan.

8

 

          (c) Any surrender by a Section 16 Grantee of previously owned shares of Common Stock to
satisfy tax withholding arising upon exercise of the Award must comply with the applicable
provisions of Rule 16b-3(e).

     12. Elective Share Withholding. A Grantee may, with the prior consent of the Committee, elect
the withholding by the Company of a portion of the Shares otherwise deliverable to such Grantee
upon the exercise of an Award or upon Restricted Shares becoming
nonforfeitable (each, a “Taxable Event”) having a Fair Market Value equal to the minimum amount necessary to satisfy the Required
Withholding liability attributable to the Taxable Event.

     13. Corporate Transactions. In the event the Board or the stockholders of the Company approve
a plan of complete liquidation or dissolution of the Company, all options will terminate
immediately prior to the consummation of such liquidation or dissolution; provided, however, that
options granted pursuant to the Automatic Option Grant Program
described in Section 7 above shall be
governed by the terms set forth in Section 7. The Committee may, in its sole discretion, declare
that any option shall terminate as of a date fixed by the Committee and give each Grantee the right
to exercise such Grantee’s option as to all or any part of the Shares subject thereto, including
Shares as to which the option would not otherwise be exercisable. In the event that the Board or
the stockholders of the Company approve an agreement for the sale of all or substantially all of
the Company’s assets or a merger, consolidation or similar transaction in which the Company will
not be the surviving entity or will survive as a wholly-owned subsidiary of another entity (each, a
“Corporate Transaction”), the option shall be assumed or an equivalent option shall be substituted
by such successor entity or a parent or subsidiary of such successor entity, unless the Board
determines, in its sole discretion and in lieu of such assumption or substitution, to take one of
the following two options: (i)fifteen (15) days prior to the scheduled consummation of such
Corporate Transaction, all options shall become immediately vested and exercisable and shall remain
exercisable for a period of fifteen days, or (ii) cancel any outstanding options and pay or
deliver, or cause to be paid or delivered, to the holder thereof an amount in cash or securities
having a value (as determined by the Board in its sole, good faith discretion) equal to the product
of the number of shares subject to the option multiplied by the amount, if any, by which (A) the
formula or fixed price per share paid to holders of shares pursuant to such Corporate Transaction
exceeds (B) the Option Price applicable to such shares. With respect to the Company’s establishment
of an exercise window, (i) any exercise of an option during such fifteen-day period shall be
conditioned upon the consummation of the contemplated Corporate Transaction and shall be effective
only immediately before the consummation of such Corporate transaction and (ii) upon consummation
of such Corporate Transaction, the Plan and all outstanding but unexercised options shall
terminate. The Board shall send written notice of the Corporate Transaction that will result in
such a termination to all individuals who hold options not later than the time at which the Company
gives notice thereof to its shareholders.

     14. Termination of Employment or Service.

          (a) For Cause. If a Grantee’s employment or service is terminated for Cause, (i) the Grantee’s
Restricted Shares and SARs that are then forfeitable shall thereupon be forfeited, subject to the
provisions of Section 6(f)(iii) regarding repayment of certain amounts to the Grantee; and (ii) any
unexercised option or Performance Share shall terminate effective immediately upon such termination
of employment or service.

          (b) On Account of Death. Except as otherwise provided by the Committee in the Award Agreement,
if a Grantee’s employment or service terminates on account of death, then:

               (i) the Grantee’s Restricted Shares that were forfeitable shall thereupon become
nonforfeitable;

               (ii) any unexercised option or SAR, to the extent exercisable on the date of such termination
of employment or service, may be exercised, in whole or in part, within the first twelve (12)
months after such termination of employment or service (but only during the Option Term) by (A) his
or her personal representative or by the person to whom the option or SAR, as applicable, is
transferred by will or the applicable laws of descent and distribution, (B) the Grantee’s
designated beneficiary, or (C) a Permitted Transferee; and, to the extent that any such option of
SAR was not exercisable on the date of such termination of employment or service, it will
immediately terminate; and

               (iii) any unexercised Performance Shares may be exercised in whole or in part, at any time
within six(6) months after such termination of employment or service on account of the death of the
Grantee, by (A) his or her personal representative or by the person to whom the Performance Shares
are transferred by will or the applicable laws of descent and distribution, (B) the Grantee’s
designated
beneficiary or (C) a Permitted Transferee, except that the benefit payable with respect to any
Performance Shares for which the Performance Period has not ended as of the date of such
termination of employment on account of death shall be equal to the product of Fair Market Value of
such Performance Shares multiplied successively by each of the following:

9

 

                    (A) a fraction, the numerator of which is the number of months (including as a whole month any
partial month) that has elapsed since the beginning of such Performance Period until the date of
such termination of employment or service and the denominator of which is the number of months
(including as a whole month any partial month) in the Performance Period; and

                    (B) a percentage determined in the discretion of the Committee that would be earned under the
terms of the applicable Award Agreement assuming that the rate at which the performance goals have
been achieved as of the date of such termination of employment or service would continue until the
end of the Performance Period, or, if the Committee elects to compute the benefit after the end of
the Performance Period, the Performance Percentage, as determined by the Committee, attained during
the Performance Period for the Performance Share.

          (c) On Account of Disability. Except as otherwise provided by the Committee in the Award
Agreement, if a Grantee’s employment or service terminates on account of Disability, then:

               (i) the Grantee’s Restricted Shares that were forfeitable shall thereupon become
nonforfeitable;

               (ii) any unexercised option or SAR, to the extent exercisable on the date of such termination
of employment, may be exercised in whole or in part, within the first twelve (12) months after such
termination of employment or service (but only during the Option Term) by the Grantee, or by (A)
his or her personal representative or by the person to whom the option or SAR, as applicable, is
transferred by will or the applicable laws of descent and distribution, (B) the Grantee’s
designated beneficiary or (C) a Permitted Transferee; and, to the extent that any such option of
SAR was not exercisable on the date of such termination of employment, it will immediately
terminate; and

               (iii) any unexercised Performance Shares may be exercised in whole or in part, at any time
within six(6) months after such termination of employment or service on account of Disability by
the Grantee, or by (A) his personal representative or by the person to whom the Performance Shares
are transferred by will or the applicable laws of descent and distribution, (B) the Grantee’s
designated beneficiary or (C) a Permitted Transferee, except that the benefit payable with respect
to any Performance Shares for which the Performance Period has not ended as of the date of such
termination of employment on account of Disability shall be equal to the product of the Fair Market
Value of the Performance Shares as of the date of exercise multiplied successively by each of the
following:

                    (A) a fraction, the numerator of which is the number of months (including as a whole month any
partial month) that have elapsed since the beginning of such Performance Period until the date of
such termination of employment or service and the denominator of which is the number of months
(including as a whole month any partial month) in the Performance Period; and

                    (B) a percentage determined in the discretion of the Committee that would be earned under the
terms of the applicable Award Agreement assuming that the rate at which the performance goals have
been achieved as of the date of such termination of employment would continue until the end of the
Performance Period, or, if the Committee elects to compute the benefit after the end of the
Performance Period, the Performance Percentage, as determined by the Committee, attained during the
Performance Period for the Performance Share.

          (d) Upon a Change of Control. The degree, if any, to which any Awards shall vest upon a Change
of Control or a termination of employment or service in connection with a Change of Control shall
be specified by the Committee in the applicable Award Agreement.

          (e) Any Other Reason. Except as otherwise provided by the Committee in the Award Agreement, if
a Grantee’s employment or service terminates for any reason other than for Cause, death, Disability
or pursuant to a Change of Control, then:

               (i) the Grantee’s Restricted Shares (and any SARs identified therewith), to the extent
forfeitable on the date of the Grantee’s termination of employment or service, shall be forfeited
on such date;

               (ii) any unexercised option or SAR (other than a SAR identified with a Restricted Share or
Performance Share), to the extent exercisable immediately before the Grantee’s termination of
employment or service, may be exercised in whole or in part, not later than three (3) months after
such termination of employment or service (but only during the Option Term); and, to the extent
that any such option of SAR was not exercisable on the date of such termination of employment or
service, it will immediately terminate; and

10

 

               (iii) the Grantee’s Performance Shares (and any SARs identified therewith) shall become
nonforfeitable and may be exercised in whole or in part, but only if and to the extent determined
by the Committee.

          (f) Repurchase Rights. If a Grantee’s employment or service with the Company is
terminated for Cause or if Grantee breaches any post-termination covenants set forth in any written
agreement between Grantee and the Company, the Company may, in its discretion, for a period of one
year after the termination for Cause, or the actual discovery by the Company of the breach, as
applicable, and upon 10 days notice to the Grantee, repurchase all or any portion of any Common
Stock acquired by the Grantee upon the Grantee’s exercise of an Award. The purchase price for any
Common Stock repurchased by the Company pursuant to this Section 14(f) shall be the lesser of the
price paid to acquire such Common Stock and the Fair Market Value thereof on the date of such
purchase by the Company.

     15. Plans of Foreign Subsidiaries. The Committee may authorize any foreign Subsidiary
to adopt a plan for granting Awards (“Foreign Plan”). All Awards granted under such Foreign Plan
shall be treated as grants under the Plan. Such Foreign Plans shall have such provisions as the
Committee permits not inconsistent with the provisions of the Plan. Awards granted under a Foreign
Plan shall be governed by the terms of the Plan, except to the extent that the provisions of the
Foreign Plan are more restrictive than the provisions of the Plan, in which case the Foreign Plan
shall control.

     16. Substituted Awards. If the Committee cancels any Award (whether granted under this
Plan or any plan of any entity acquired by the Company or a Subsidiary), the Committee may, in its
discretion, substitute a new Award therefor upon such terms and conditions consistent with the Plan
as the Committee may determine, except that (a) the Option Price of any new option, and the Strike
Price of any new SAR, shall not be less than one hundred percent (100%) (one hundred ten
percent(110%) in the case of an incentive stock option granted to a Ten Percent Owner) of the Fair
Market Value of a Share on the date of the grant of the new Award; and (b) the Grant Date of the
new Award shall be the date on which such new Award is granted.

     17. Securities Law Matters.

          (a) Compliance. If the Committee deems it necessary to comply with any applicable securities
law, the Committee may require a written investment intent representation by the Grantee and may
require that a restrictive legend be affixed to certificates for Shares. If, based upon the advice
of counsel to the Company, the Committee determines that the exercise or nonforfeitability of, or
delivery of benefits pursuant to, any Award would violate any applicable provision of (i)federal or
state securities or blue-sky laws or regulations or (ii) the listing requirements of any national
exchange or national market system on which are listed any of the Company’s equity securities, then
the Committee may postpone any such exercise, nonforfeitability or delivery, as applicable, but the
Company shall use all reasonable efforts to cause such exercise, nonforfeitability or delivery to
comply with all such provisions at the earliest practicable date.

          (b) Section 16. Grants of options to Section 16 Grantees shall comply with Rule 16b-3 and
shall contain such additional conditions or restrictions as may be required thereunder for such
grants to qualify for exemption from liability under Section 16(b) of the 1934 Act.

     18.
No Employment Rights. Neither the establishment of the Plan nor the grant of any
Award shall (a) give any Grantee the right to remain employed or otherwise engaged, hired or
retained by the Company or any Subsidiary, or entitle any Grantee to any benefits not specifically
provided by the Plan or (b) modify the right of the Company or any Subsidiary to modify, amend, or
terminate any employee benefit plan.

     19. No Rights as a Shareholder. A Grantee shall not have any rights as a shareholder
of the Company with respect to the Shares (other than Restricted Shares) which may be deliverable
upon exercise or payment of such Award until such shares have been delivered to him or her.
Restricted Shares, whether held by a Grantee or in escrow by the Company, shall confer on the
Grantee all rights of a shareholder of
the Company, except as otherwise provided in the Plan or in the applicable Award Agreement. At
the time of a grant of Restricted Shares, the Committee may require the payment of cash dividends
thereon to be deferred and, if the Committee so determines, reinvested in additional Restricted
Shares. Stock dividends or deferred cash dividends issued with respect to Restricted Shares shall
be subject to the same restrictions and other terms as apply to the Restricted Shares with respect
to which such dividends are issued. The Committee may in its discretion provide for payment of
interest on deferred cash dividends.

     20. Nature of Payments. Awards shall be special incentive payments to the Grantee and
shall not be taken into account in computing the amount of salary or compensation of the Grantee
for purposes of determining any pension, retirement, death, or other benefit under (a) any pension,
retirement, profit-sharing, bonus, insurance, or other employee benefit plan of the Company or any

11

 

Subsidiary or (b) any agreement between (i) the Company or any Subsidiary and (ii) the Grantee,
except as such plan or agreement shall otherwise expressly provide.

     21. Non-Uniform Determinations. The Committee’s determinations under the Plan need not
be uniform and may be made by the Committee selectively among persons who receive, or are eligible
to receive, Awards, whether or not such persons are similarly situated. Without limiting the
generality of the foregoing, the Committee shall be entitled, to enter into non-uniform and
selective Award Agreements as to (a) the identity of the
Grantees, (b) the terms and provisions of Awards and (c) the
treatment of terminations of employment or service.

     22. Adjustments. The Committee shall make equitable adjustment of:

          (a) the aggregate number of Shares available under the Plan for Awards and the aggregate
number of Shares for which Awards may be granted to any individual Grantee in any calendar year
pursuant to the second sentence of Section 2;

          (b) the number of Shares, SARs or Performance Shares covered by an Award; and

          (c) the Option Price of all outstanding options and the Strike Price of all outstanding
SARs;

to reflect a stock dividend, stock split, reverse stock split, share combination, recapitalization,
merger, consolidation, spin-off, split-off, reorganization, rights offering, liquidation or similar
event, of or by the Company.

     23. Amendment of the Plan. The Committee may from time to time, in its discretion,
amend the Plan without the approval of the Company’s shareholders, except (a) as such shareholder
approval may be required under the listing requirements of any securities exchange or national
market system on which are listed the Company’s equity securities and (b) that the Committee may
not without the approval of the Company’s shareholders amend the Plan to increase the total number
of shares reserved for the purposes of the Plan.

     24. Termination of the Plan. The Plan shall continue in effect until the earlier of
its termination by the Committee or the date on which all of the shares of Common Stock available
for issuance under the Plan have been issued and all restrictions on such Shares under the terms of
the Plan and the agreements evidencing Awards granted under the Plan have lapsed. However, all
Awards shall be granted, if at all, within ten (10) years from the earlier of the date the Plan is
adopted by the Board or the date the Plan is duly approved by the shareholders of the Company.
Notwithstanding the foregoing, if the maximum number of shares of Common Stock issuable pursuant to
the Plan has been increased at any time, all Awards shall be granted, if at all, no later than the
last day preceding the ten (10) year anniversary of the earlier of (a) the date on which the latest
such increase in the maximum number of shares of Common Stock issuable under the Plan was approved
by the shareholders of the Company or (b) the date such amendment was adopted by the Board. No
termination shall affect any Award then outstanding under the Plan.

     25. No Illegal Transactions. The Plan and all Awards granted pursuant to it are
subject to all applicable laws and regulations. Notwithstanding any provision of the Plan or any
Award, Grantees shall not be entitled to exercise, or receive benefits under, any Award, and the
Company shall not be obligated to deliver any Shares or deliver benefits to a Grantee, if such
exercise or delivery would constitute a violation by the Grantee or the Company of any applicable
law or regulation.

     26. Constructive Sales. The Grantee shall not directly or indirectly, through related
parties or otherwise, sell “short” or “short against the box” (as those terms are generally
understood in the securities markets), or otherwise directly or indirectly (through derivative
instruments or otherwise) dispose of or hedge, any securities of the Company issuable upon exercise
of such Grantee’s Award(s). The foregoing provision may, at the discretion of the Committee, be
reflected in the individual Award Agreements governing the terms and conditions of the Awards
granted by the Company to the Grantees (which shall be entered into following the grant of such
Awards by the Committee).

     27.
Definitions. The terms set forth below have the indicated meanings which are
applicable to both the singular and plural forms thereof:

          (a) “Award” shall mean options, including ISOs, Restricted Shares, Bonus Shares, SARs
or Performance Shares granted under the Plan.

          (b) “Award Agreement” shall mean the written agreement by which an Award shall
be evidenced.

12

 

          (c) “Board” shall mean the Board of Directors of the Company.

          (d) “Bonus Shares” shall mean Shares that are awarded to a Grantee without cost
and without restrictions.

          (e) “Cause”, with respect to any employee or consultant of the Company shall have the
meaning set forth in such person’s employment, consulting or other applicable agreement, or, in the
absence of any such agreement or if such term is not defined in any such agreement, shall mean any
one or more of the following, as determined by the Committee (in the case of a Section 16 Grantee)
or the Chief Executive Officer or President of the Company (in the case of any other Grantee):

               (i) a Grantee’s commission of a crime that is likely to result in injury to the
Company or subsidiary;

               (ii) the material violation by the Grantee of written policies of the Company or a
Subsidiary;

               (iii) the habitual neglect by the Grantee in the performance of his or her duties
to the Company or subsidiary; or

               (iv) a Grantee’s willful misconduct or inaction in
connection with his or her duties to the Company or a Subsidiary.

          (f) “Change of Control” shall mean the occurrence of any of the following events:

               (i) Any
“person”, as such term is currently used in Section 13(d) or 14(d) of the 1934 Act,
other than any employee benefit plan of the Company, becomes a “beneficial owner” (as such term is
currently used in Rule 13d-3 promulgated under the 1934 Act) of 50% or more of the number of shares
of the Company’s voting stock;

               (ii) The Board adopts any plan of liquidation providing for the distribution of all or
substantially all of the Company’s assets;

               (iii) All or substantially all of the assets or business of the Company is disposed of
pursuant to a sale, merger, consolidation or other transaction, unless the shareholders of the
Company immediately prior to such transaction beneficially own (within the meaning of Rule 13d-3
promulgated under the 1934 Act) as a result of their ownership of stock in the Company, at least 50%
of the number of shares of voting stock or other voting equity of the entity or entities that
succeed to the business of the Company; or

               (iv) The Company combines with another company and is the surviving corporation but,
immediately after the combination, the shareholders of the Company immediately before such
transaction beneficially own (within the meaning of Rule 13d-3 promulgated under the 1934 Act) as a
result of their ownership of stock in the Company, less than 50% of the number of shares of voting
stock of the combined company.

          (g) “Code” shall mean the Internal Revenue Code of 1986, as amended or superseded, and
the regulations and rulings thereunder. Reference to a particular section of the Code shall include
references to successor provisions.

          (h) “Committee” shall mean the committee of the Board appointed pursuant to Section
3(a), or if not so appointed, shall mean the entire Board.

          (i) “Common Stock” shall mean the common stock, $.001 par value per share, of
the Company.

          (j) “Consultant” shall mean any person, including a Director, who is engaged by the
Company or any parent, Subsidiary or affiliate thereof, to render services to or for the benefit of
the Company and is compensated for such services.

          (k) “Director” shall mean a member of the Board.

          (l) “Disability” shall mean a permanent and total disability, within the
meaning of Section 22(e)(3) of the Code.

          (m) “Effective Date” shall mean the date set forth in the first paragraph hereof,
provided that the Company’s stockholder within one (1) year of the Effective Date approve the
adoption of the Plan.

13

 

          (n) “Eligible Person” shall mean any Employee, Consultant or Director of the Company
or any Subsidiary, including any prospective Employee or Employee on an approved leave of absence
or layoff, if such leave or layoff does not qualify as a Disability.

          (o) “Employee” shall mean any person treated as an employee (including officers and
directors) in the records of the Company and who is subject to the control and direction of the
Company with regard to both the work to be performed and the manner and method of performance. The
payment of a director’s fee by the Company to a Director shall not be sufficient to constitute
“employment” of the Director by the Company.

          (p) “Fair Market Value” per share of Common Stock on any relevant date shall mean such
value as determined in accordance with the following provisions:

               (i) If the Common Stock is at that time listed on a national securities exchange, then the
Fair Market Value shall mean the closing selling price per share of Common Stock on the exchange on
which such Common Stock is principally traded on the relevant date or, if there were no sales on
that date, the closing selling price of such Common Stock on the last preceding date on which there
were sales.

               (ii) If the Common Stock is at that time traded on the Nasdaq National Market®, Nasdaq Small
Cap MarketSM or OTC Bulletin Board®, as the case may be, then the Fair Market Value shall mean the
closing selling price per share of Common Stock on the relevant date, as the price is reported by
the National Association of Securities Dealers, Inc., on the Nasdaq National Market®, Nasdaq Small
Cap MarketSM or OTC Bulletin Board®, as the case may be, or any successor system. If there is no
closing selling price for the Common Stock on the relevant date, then the Fair Market Value shall
mean the closing selling price on the last preceding date for which such quotation exists.

               (iii) If the Common Stock is neither listed on any national securities exchange nor traded on
the Nasdaq National Market®, Nasdaq Small Cap MarketSM or OTC Bulletin Board®, then the Fair Market
Value shall mean the value per share of Common Stock as determined by the Board after taking into
account such factors as the Board shall in good faith deem appropriate.

          (q) “Grant Date” shall have the meaning specified in Section 6(a)(i).

          (r) “Grantee” shall mean an individual who has been granted an Award or any
Permitted Transferee.

          (s) “Hostile Tender-Offer” shall mean the acquisition, directly or indirectly, by any
person or related group of persons (other than the Company or a person that directly or indirectly
controls, is controlled by, or is under common control with, the Company) of beneficial ownership
(within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent
(50%) of the total combined voting power of the Company’s outstanding securities pursuant to a
tender or exchange offer made directly to the Company’s stockholders which the Board does not
recommend such stockholders to accept.

          (t) “Immediate Family” shall mean, with respect to a particular Grantee, the Grantee’s
spouse, children and grandchildren.

          (u) “ISO” shall mean an incentive stock option within the meaning of Section
422 of the Code.

          (v) “Mature Shares” shall mean Shares for which the holder thereof has good title,
free and clear of all liens, encumbrances and restrictions, and which such holder has held for at
least six (6) months.

          (w) “Minimum Consideration” shall mean $.001 per Share or such other amount that is
from time to time considered to be capital for purposes of the General Corporation Law of the State
of Delaware.

          (x) “1934 Act” shall mean the Securities Exchange Act of 1934, as amended. References
to a particular section of the 1934 Act or rule thereunder, include references to successor
provisions.

          (y) “Option Price” shall mean the per share exercise price of an option.

          (z) “Option Term” shall mean the period beginning on the Grant Date of an option and
ending on the expiration date of such option, as specified in the Award Agreement for such option
and as may, in the discretion of the Committee and consistent

14

 

with the provisions of the Plan, be extended from time to time.

          (aa) “Performance Shares” shall mean an Award to a Grantee pursuant to Section
6(e).

          (bb) “Permitted Transferee” shall mean a person to whom an Award may be transferred or
assigned in accordance with Section 7.

          (cc) “Restricted Shares” shall mean Shares that are subject to forfeiture if the
Grantee does not satisfy the conditions specified in the Award Agreement applicable to those
Shares.

          (dd) “Rule 16b-3” shall mean Rule 16b-3 as promulgated under the 1934 Act, as amended
from time to time, together with any successor rule.

          (ee) “SAR” shall mean a stock appreciation right.

          (ff) “Section 16 Grantee” shall mean a person who is subject to potential liability
under Section 16(b) of the 1934 Act with respect to transactions involving equity securities of the
Company.

          (gg) “Share” shall mean a share of Common Stock.

          (hh) “Strike Price” shall have the meaning specified in Section 6(d)(ii).

          (ii) “Subsidiary” shall mean a subsidiary corporation as defined in Section 424(f) of
the Code (with the Company being treated as the employer corporation for purposes of this
definition).

          (jj)
“Tender-Offer Price” shall mean the greater of (i) the Fair Market Value per
share of Common Stock on the date the option is surrendered to the Company in connection with a
Hostile Tender-Offer or (ii) the highest reported price per share of Common Stock paid by the
tender offeror in effecting such Hostile Tender-Offer. However, if the surrendered option is an
ISO, the Tender-Offer Price shall not exceed the clause (i) price per share.

          (kk) “Ten Percent Owner” shall mean a person who owns capital stock (including stock
treated as owned under Section 424(d) of the Code) possessing more than ten percent of the total
combined Voting Power of all classes of capital stock of the Company or any Subsidiary.

          (ll) “Voting Power” shall mean the combined voting power of the then-outstanding
securities of the Company entitled to vote generally in the election of directors.

     28. Controlling Law. The law of the State of Delaware, except its law with respect to
choice of law, shall control all matters relating to the Plan.

     29. Severability. If any part of the Plan is declared by any court or governmental
authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any other
part of the Plan. Any Section or part of a Section so declared to be unlawful or invalid shall, if
possible, be construed in a manner which will given effect to the terms of such Section to the
fullest extent possible while remaining lawful and valid.

	 	 	 
	Amendments:
	 	 
	By Stockholders -

	 	July 20, 2006
	By Board of Directors -

	 	September 21, 2006
	By Compensation Committee -

	 	March 8, 2006
	By Stockholders -

	 	June 26, 2007
	By Board of Directors -

	 	October                     , 2007

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]